Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT01089790
Other study ID # DUT-MD-403
Secondary ID
Status Terminated
Phase Phase 3
First received March 17, 2010
Last updated September 14, 2011
Start date March 2010

Study information

Verified date September 2011
Source Forest Laboratories
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug AdministrationBelarus: Ministry of HealthColombia: INVIMA Instituto Nacional de Vigilancia de Medicamentos y AlimentosHungary: National Institute of PharmacyIndia: Drugs Controller General of IndiaLithuania: State Medicine Control Agency - Ministry of HealthPeru: Ministry of HealthRomania: State Institute for Drug ControlGermany: Federal Institute for Drugs and Medical Devices
Study type Interventional

Clinical Trial Summary

This study will evaluate the long-term safety and efficacy of dutogliptin in patients with type 2 diabetes mellitus (T2DM).


Recruitment information / eligibility

Status Terminated
Enrollment 141
Est. completion date
Est. primary completion date August 2010
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 86 Years
Eligibility Inclusion Criteria:

- Have successfully completed all required visits of a qualifying Phase 3 core protocol

- Be currently receiving treatment for T2DM as set forth in the qualifying Phase 3 core protocol

Exclusion Criteria:

- Any condition, disease, disorder or clinically relevant laboratory abnormality which, in the opinion of the investigator, would jeopardize the patient's appropriate participation in this study or obscure the effects of treatment

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
Dutogliptin
400 mg tablet, once daily
Sitagliptin
100 mg capsule (each capsule contains two 50-mg tablets), once daily

Locations

Country Name City State
United States Forest Investigative Site 039 Akron Ohio
United States Forest Investigative Site 006 Albany New York
United States Forest Investigative Site 101 Albuquerque New Mexico
United States Forest Investigative Site 137 Albuquerque New Mexico
United States Forest Investigative Site 061 Anaheim California
United States Forest Investigative Site 152 Anaheim California
United States Forest Investigative Site 099 Arlington Texas
United States Forest Investigative Site 121 Arlington Virginia
United States Forest Investigative Site 155 Asheboro North Carolina
United States Forest Investigative Site 102 Ashland Oregon
United States Forest Investigative Site 045 Atlanta Georgia
United States Forest Investigative Site 079 Augusta Georgia
United States Forest Investigative Site 035 Baltimore Maryland
United States Forest Investigative Site 130 Bensalem Pennsylvania
United States Forest Investigative Site 147 Berkeley Heights New Jersey
United States Forest Investigative Site 083 Bethany Oklahoma
United States Forest Investigative Site 020 Birmingham Alabama
United States Forest Investigative Site 064 Birmingham Alabama
United States Forest Investigative Site 156 Boca Raton Florida
United States Forest Investigative Site 148 Brandenton Florida
United States Forest Investigative Site 048 Bristol Tennessee
United States Forest Investigative Site 003 Brockton Massachusetts
United States Forest Investigative Site 055 Brockton Massachusetts
United States Forest Investigative Site 163 Cadillac Michigan
United States Forest Investigative Site 059 Chandler Arizona
United States Forest Investigative Site 051 Charlotte North Carolina
United States Forest Investigative Site 094 Charlotte North Carolina
United States Forest Investigative Site 117 Charlotte North Carolina
United States Forest Investigative Site 104 Chattanooga Tennessee
United States Forest Investigative Site 114 Chattanooga Tennessee
United States Forest Investigative Site 041 Chula Vista California
United States Forest Investigative Site 023 Cincinnati Ohio
United States Forest Investigative Site 073 Clearwater Florida
United States Forest Investigative Site 115 Colorado Springs Colorado
United States Forest Investigative Site 043 Columbus Ohio
United States Forest Investigative Site 056 Corpus Christi Texas
United States Forest Investigative Site 034 Covington Louisiana
United States Forest Investigative Site 017 Dallas Texas
United States Forest Investigative Site 071 Dallas Texas
United States Forest Investigative Site 124 Dallas Texas
United States Forest Investigative Site 057 Dayton Ohio
United States Forest Investigative Site 004 Daytona Beach Florida
United States Forest Investigative Site 002 Dearborn Michigan
United States Forest Investigative Site 077 Decatur Georgia
United States Forest Investigative Site 052 DeLand Florida
United States Forest Investigative Site 088 Denver Colorado
United States Forest Investigative Site 162 Desoto Texas
United States Forest Investigative Site 042 Dunwoody Georgia
United States Forest Investigative Site 135 Durham North Carolina
United States Forest Investigative Site 054 Edina Minnesota
United States Forest Investigative Site 049 Encinitas California
United States Forest Investigative Site 078 Erlanger Kentucky
United States Forest Investigative Site 005 Eugene Oregon
United States Forest Investigative Site 097 Evansville Indiana
United States Forest Investigative Site 100 Evansville Indiana
United States Forest Investigative Site 113 Gilbert Arizona
United States Forest Investigative Site 096 Goodyear Arizona
United States Forest Investigative Site 013 Grand Island Nebraska
United States Forest Investigative Site 022 Greenbrae California
United States Forest Investigative Site 103 Greer South Carolina
United States Forest Investigative Site 047 Harbor City California
United States Forest Investigative Site 037 Harleysville Pennsylvania
United States Forest Investigative Site 144 Hialeah Florida
United States Forest Investigative Site 129 Hollywood Florida
United States Forest Investigative Site 106 Houston Texas
United States Forest Investigative Site 136 Houston Texas
United States Forest Investigative Site 010 Huntington Park California
United States Forest Investigative Site 014 Irving Texas
United States Forest Investigative Site 139 Irving Texas
United States Forest Investigative Site 062 Jacksonville Florida
United States Forest Investigative Site 126 Jenkintown Pennsylvania
United States Forest Investigative Site 053 Kansas City Kansas
United States Forest Investigative Site 032 Kettering Ohio
United States Forest Investigative Site 065 Las Vegas Nevada
United States Forest Investigative Site 072 Las Vegas Nevada
United States Forest Investigative Site 058 Lenoir North Carolina
United States Forest Investigative Site 107 Lexington Kentucky
United States Forest Investigative Site 070 Los Angeles California
United States Forest Investigative Site 024 Madisonville Kentucky
United States Forest Investigative Site 090 Manning South Carolina
United States Forest Investigative Site 141 Marion Ohio
United States Forest Investigative Site 159 Marion Ohio
United States Forest Investigative Site 001 Medford Oregon
United States Forest Investigative Site 009 Meridian Idaho
United States Forest Investigative Site 050 Miami Florida
United States Forest Investigative Site 122 Miami Florida
United States Forest Investigative Site 154 Miami Florida
United States Forest Investigative Site 157 Miami Florida
United States Forest Investigative Site 161 Miami Florida
United States Forest Investigative Site 125 Miami Lakes Florida
United States Forest Investigative Site 027 Milwaukee Wisconsin
United States Forest Investigative Site 038 Morehead City North Carolina
United States Forest Investigative Site 158 Morrisville Pennsylvania
United States Forest Investigative Site 025 Muscle Shoals Alabama
United States Forest Investigative Site 118 New Bedford Massachusetts
United States Forest Investigative Site 160 New Braunfels Texas
United States Forest Investigative Site 081 New Hyde Park New York
United States Forest Investigative Site 069 New Port Richey Florida
United States Forest Investigative Site 016 New York New York
United States Forest Investigative Site 151 New York New York
United States Forest Investigative Site 149 Norman Oklahoma
United States Forest Investigative Site 111 Northridge California
United States Forest Investigative Site 012 Ocala Florida
United States Forest Investigative Site 150 Omaha Nebraska
United States Forest Investigative Site 015 Orlando Florida
United States Forest Investigative Site 131 Ormond Beach Florida
United States Forest Investigative Site 046 Oxon Hill Maryland
United States Forest Investigative Site 033 Pelzer South Carolina
United States Forest Investigative Site 127 Pembroke Pines Florida
United States Forest Investigative Site 030 Peoria Illinois
United States Forest Investigative Site 080 Peoria Arizona
United States Forest Investigative Site 066 Philadelphia Pennsylvania
United States Forest Investigative Site 098 Phoenix Arizona
United States Forest Investigative Site 133 Phoenix Arizona
United States Forest Investigative Site 068 Renton Washington
United States Forest Investigative Site 031 Riverside California
United States Forest Investigative Site 165 Rockville Maryland
United States Forest Investigative Site 091 Roseville California
United States Forest Investigative Site 084 Roswell Georgia
United States Forest Investigative Site 132 Roswell Georgia
United States Forest Investigative Site 067 Sacramento California
United States Forest Investigative Site 140 Sacramento California
United States Forest Investigative Site 040 Salisbury North Carolina
United States Forest Investigative Site 076 Salt Lake City Utah
United States Forest Investigative Site 109 San Antonio Texas
United States Forest Investigative Site 119 San Antonio Texas
United States Forest Investigative Site 146 San Antonio Texas
United States Forest Investigative Site 145 San Mateo California
United States Forest Investigative Site 112 Santa Ana California
United States Forest Investigative Site 018 Sarasota Florida
United States Forest Investigative Site 044 Scottsdale Arizona
United States Forest Investigative Site 092 Spokane Washington
United States Forest Investigative Site 123 Springfield Illinois
United States Forest Investigative Site 075 St Petersburg Florida
United States Forest Investigative Site 029 St. Clair Shores Michigan
United States Forest Investigative Site 142 St. Louis Missouri
United States Forest Investigative Site 143 St. Louis Missouri
United States Forest Investigative Site 138 Tamarac Florida
United States Forest Investigative Site 036 Tipton Pennsylvania
United States Forest Investigative Site 087 Tucson Arizona
United States Forest Investigative Site 128 Tustin California
United States Forest Investigative Site 028 Virginia Beach Virginia
United States Forest Investigative Site 011 Walnut Creek California
United States Forest Investigative Site 007 Waltham Massachusetts
United States Forest Investigative Site 063 West Hills California
United States Forest Investigative Site 026 West Palm Beach Florida
United States Forest Investigative Site 008 Wichita Kansas
United States Forest Investigative Site 082 Winston-Salem North Carolina
United States Forest Investigative Site 153 Zanesville Ohio

Sponsors (2)

Lead Sponsor Collaborator
Forest Laboratories Phenomix

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary To demonstrate safety and tolerability of dutogliptin as assessed by vital signs, adverse event reporting, routine clinical laboratory assessments, and ECG 52 weeks Yes
Secondary To demonstrate maintenance or lowering of HbA1c and fasting plasma glucose. 52 weeks No
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05666479 - CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
Completed NCT05647083 - The Effect of Massage on Diabetic Parameters N/A
Active, not recruiting NCT05661799 - Persistence of Physical Activity in People With Type 2 Diabetes Over Time. N/A
Completed NCT03686722 - Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin Phase 1
Completed NCT02836704 - Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose) Phase 4
Completed NCT01819129 - Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes Phase 3
Completed NCT04562714 - Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy N/A
Completed NCT02009488 - Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM) Phase 1
Completed NCT05896319 - Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2 N/A
Recruiting NCT05598203 - Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes N/A
Completed NCT05046873 - A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People Phase 1
Completed NCT04030091 - Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus Phase 4
Terminated NCT04090242 - Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes N/A
Completed NCT03620357 - Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D) N/A
Completed NCT03604224 - A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
Completed NCT01696266 - An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
Completed NCT03620890 - Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy Phase 4
Withdrawn NCT05473286 - A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
Not yet recruiting NCT05029804 - Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes N/A
Completed NCT04531631 - Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes Phase 2